172 related articles for article (PubMed ID: 32956151)
1. Association of Hydroxychloroquine use and Hemolytic Anemia in Patients With Low Levels of Glucose-6-Phosphate Dehydrogenase.
Ramirez de Oleo IE; Mejia Saldarriaga M; Johnson BK
J Clin Rheumatol; 2022 Jan; 28(1):e23-e25. PubMed ID: 32956151
[TBL] [Abstract][Full Text] [Related]
2. Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients.
Mohammad S; Clowse MEB; Eudy AM; Criscione-Schreiber LG
Arthritis Care Res (Hoboken); 2018 Mar; 70(3):481-485. PubMed ID: 28556555
[TBL] [Abstract][Full Text] [Related]
3. Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
Onori ME; Ricciardi Tenore C; Urbani A; Minucci A
Mol Biol Rep; 2021 Mar; 48(3):2973-2978. PubMed ID: 33620659
[TBL] [Abstract][Full Text] [Related]
4. Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
Zuchelkowski BE; Wang L; Gingras S; Xu Q; Yang M; Triulzi D; Page GP; Gordeuk VR; Kim-Shapiro DB; Lee JS; Gladwin MT
PLoS One; 2020; 15(10):e0240266. PubMed ID: 33007039
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.
Serpa JA; Villarreal-Williams E; Giordano TP
J Infect; 2010 Nov; 61(5):399-402. PubMed ID: 20732351
[TBL] [Abstract][Full Text] [Related]
6. Study of Glucose-6-Phosphate Dehydrogenase Deficiency: 5 Years Retrospective Egyptian Study.
Hagag AA; Badraia IM; Elfarargy MS; Abd Elmageed MM; Abo-Ali EA
Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):155-162. PubMed ID: 28982343
[TBL] [Abstract][Full Text] [Related]
7. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Belfield KD; Tichy EM
Am J Health Syst Pharm; 2018 Feb; 75(3):97-104. PubMed ID: 29305344
[TBL] [Abstract][Full Text] [Related]
8. Discussion on pharmacogenetic interaction in G6PD deficiency and methods to identify potential hemolytic drugs.
Manganelli G; Fico A; Martini G; Filosa S
Cardiovasc Hematol Disord Drug Targets; 2010 Jun; 10(2):143-50. PubMed ID: 20350285
[TBL] [Abstract][Full Text] [Related]
9. Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.
Elyassi AR; Rowshan HH
Anesth Prog; 2009; 56(3):86-91. PubMed ID: 19769422
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
Aguilar J; Averbukh Y
Perm J; 2020; 24():. PubMed ID: 33183501
[TBL] [Abstract][Full Text] [Related]
11. Should blood donors be routinely screened for glucose-6-phosphate dehydrogenase deficiency? A systematic review of clinical studies focusing on patients transfused with glucose-6-phosphate dehydrogenase-deficient red cells.
Renzaho AM; Husser E; Polonsky M
Transfus Med Rev; 2014 Jan; 28(1):7-17. PubMed ID: 24289973
[TBL] [Abstract][Full Text] [Related]
12. A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
Abramova I; Park K; Hosny C; Tuladhar S; Yao Q; Patnaik A
Cureus; 2020 Aug; 12(8):e9519. PubMed ID: 32884875
[TBL] [Abstract][Full Text] [Related]
13. Hemolysis After Medication Exposure in Pediatric Patients With G6PD Deficiency.
Doshi BS; Kamdar A; Lambert MP; Obstfeld AE
J Pediatr Hematol Oncol; 2022 Jul; 44(5):261-263. PubMed ID: 34654762
[TBL] [Abstract][Full Text] [Related]
14. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
[TBL] [Abstract][Full Text] [Related]
15. Pattern of Hemolytic Anemia Among Egyptian Pediatric Emergency Department Patients.
Badr MSEM; Afifi RAA
Pediatr Emerg Care; 2020 Mar; 36(3):153-157. PubMed ID: 32108744
[TBL] [Abstract][Full Text] [Related]
16. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Youngster I; Arcavi L; Schechmaster R; Akayzen Y; Popliski H; Shimonov J; Beig S; Berkovitch M
Drug Saf; 2010 Sep; 33(9):713-26. PubMed ID: 20701405
[TBL] [Abstract][Full Text] [Related]
17. A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
Maillart E; Leemans S; Van Noten H; Vandergraesen T; Mahadeb B; Salaouatchi MT; De Bels D; Clevenbergh P
Infect Dis (Lond); 2020 Sep; 52(9):659-661. PubMed ID: 32496938
[TBL] [Abstract][Full Text] [Related]
18. Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype.
Gammal RS; Pirmohamed M; Somogyi AA; Morris SA; Formea CM; Elchynski AL; Oshikoya KA; McLeod HL; Haidar CE; Whirl-Carrillo M; Klein TE; Caudle KE; Relling MV
Clin Pharmacol Ther; 2023 May; 113(5):973-985. PubMed ID: 36049896
[TBL] [Abstract][Full Text] [Related]
19. Glucose-6-Phosphate Dehydrogenase Deficiency: An Overview of the Prevalence and Genetic Variants in Saudi Arabia.
Hamali HA
Hemoglobin; 2021 Sep; 45(5):287-295. PubMed ID: 35156495
[TBL] [Abstract][Full Text] [Related]
20. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency.
Cheah CY; Lew TE; Seymour JF; Burbury K
Acta Haematol; 2013; 130(4):254-9. PubMed ID: 23860572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
